Frazier Life Sciences Management, L.P. Revolution Medicines, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.59 Billion
- Q1 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 997,455 shares of RVMD stock, worth $37.8 Million. This represents 2.22% of its overall portfolio holdings.
Number of Shares
997,455
Previous 997,455
-0.0%
Holding current value
$37.8 Million
Previous $43.6 Million
19.16%
% of portfolio
2.22%
Previous 2.62%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$629 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$513 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$508 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$446 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$386 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.32B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...